Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort-Reference-Cited by-同舟云学术

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Published:2021-08 Issue:2 Volume:75 Page:284-291
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Harrison Stephen A.^ORCID,Gawrieh Samer^ORCID,Roberts Katharine,Lisanti Christopher J.^ORCID,Schwope Ryan B.,Cebe Katherine M.,Paradis Valerie^ORCID,Bedossa Pierre,Aldridge Whitehead Jennifer M.,Labourdette Aymeric,Miette Véronique,Neubauer Stefan,Fournier Céline,Paredes Angelo H.,Alkhouri Naim

Publisher

Elsevier BV

Subject

Hepatology

Reference40 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Histopathology, grading and staging of nonalcoholic fatty liver disease;Kleiner;Minerva Gastroenterol Dietol,2018

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

4. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications;Angulo;Semin Liver Dis,2015

5. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD;Hagstrom;J Hepatol,2017

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking;Journal of Pharmacy and Pharmacology;2024-09-09

2. Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH;Journal of Medicinal Chemistry;2024-09-02

3. Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study;Journal of Managed Care & Specialty Pharmacy;2024-09

4. Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD;Cell Reports Medicine;2024-09

5. Deep Learning Based Shear Wave Detection and Segmentation Tool for Use in Point-of-Care for Chronic Liver Disease Assessments;Ultrasound in Medicine & Biology;2024-09